Companies / EDITAS Medicine
EDITAS Medicine
Cambridge, United States
Editas Medicine develops transformative and durable medicines for people living with serious diseases using CRISPR gene editing technology
EDITAS Medicine, based in Cambridge, United States, has 4 investors on file, among them Biomatics Capital, Casdin Capital and Omega Funds. Its site was last checked 13 Nov 2026: site answers.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get EDITAS Medicine and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Biomatics Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/editasmedicine.com/investors
# also
GET /v1/companies/editasmedicine.com
GET /v1/companies/editasmedicine.com/news